Results
1 -
10 of
87Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis, Digestive Diseases and Sciences Enzymatic synthesis of 1,3-dicapryloyl-2-eicosapentaenoylglycerol, Journal of the American Oil Chemists' Society Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid, Journal of Clinical Immunology Update on pharmacotherapy of borderline personality disorder, Current Psychiatry Reports Treatment of Huntington Disease, Current Treatment Options in Neurology One-step transesterification reaction using methanol-stable lipase for omega-3 fatty acid ethyl ester production, Journal of the Korean Society for Applied Biological Chemistry Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200u2013500??mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study, Cardiovascular Diabetology A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E), Progress in Drug Research Phase 1 Study of the Effect of Icosapent Ethyl on Warfarin Pharmacokinetic and Anticoagulation Parameters, Clinical Drug Investigation Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series, Drugs & Therapy Perspectives